About Seladelpar Seladelpar is a medication used for the treatment of primary biliary cholangitis. It is…
About Infigratinib Infigratinib is a fibroblast growth factor receptor (FGFR) kinase inhibitor used in the treatment…
About Infigratinib Infigratinib is a fibroblast growth factor receptor (FGFR) kinase inhibitor used in the treatment…
About Pretomanid Pretomanid is used as a part of combination dosing regimen with bedaquiline and linezolid…
Taletrectinib is a potent, orally active, and next-generation selective ROS1/NTRK inhibitor. Taletrectinib potently inhibits recombinant ROS1, NTRK1,…
About Pacritinib Pacritinib is a medication used to treat adults with intermediate- or high-risk myelofibrosis (MF),…
About Aumolertinib Aumseqa (INN: Aumolertinib) (previously known as almonertinib) is a EGFR tyrosine kinase inhibitor targeting…
About Vandetanib Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the…
About Vandetanib Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the…
About Lenacapavir Lenacapavir is a prescription medicine approved by the FDA for the treatment of HIV…
About Capivasertib Capivasertib is an orally bioavailable, small-molecule inhibitor of all three AKT isoforms. Capivasertib used…
About Capivasertib Capivasertib is an orally bioavailable, small-molecule inhibitor of all three AKT isoforms. Capivasertib used…
About Ritlecitinib Ritlecitinib is a kinase inhibitor which inhibits Janus kinase 3 and tyrosine kinase. Ritlecitinib…
Lazertinib is a potent irreversible, brain-penetrant, third-generation EGFR TKI exhibiting high selectivity for both activating and…
About Idelalisib Idelalisib is a medication used to treat certain blood cancers. Idelalisib acts as a phosphoinositide 3-kinase…
About Cobimetinib Cobimetinib is a MEK inhibitor. Cobimetinib is an anti-cancer medication used to treat melanoma and histiocytic neoplasms. Melanoma Indicated…
Copyright © 2021-2022 LienTeh.net All rights reserved.
